{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:13:36Z","timestamp":1788452016904,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:00:00Z","timestamp":1265932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:00:00Z","timestamp":1265932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1038\/cgt.2010.6","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T11:22:43Z","timestamp":1265973763000},"page":"457-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Bleomycin\/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs"],"prefix":"10.1038","volume":"17","author":[{"given":"S D","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Buckholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cutrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Shiomitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,12]]},"reference":[{"key":"BFcgt20106_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-59745-194-9_1","volume":"423","author":"LM Mir","year":"2008","unstructured":"Mir LM . Application of electroporation gene therapy: past, current, and future. Methods Mol Biol 2008; 423: 3\u201317.","journal-title":"Methods Mol Biol"},{"key":"BFcgt20106_CR2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/089686080602600603","volume":"26","author":"M Miyazaki","year":"2006","unstructured":"Miyazaki M, Obata Y, Abe K, Furusu A, Koji T, Tabata Y et al. Gene transfer using nonviral delivery systems. Perit Dial Int 2006; 26: 633\u2013640.","journal-title":"Perit Dial Int"},{"key":"BFcgt20106_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbagen.2005.05.006","volume":"1724","author":"J Teissie","year":"2005","unstructured":"Teissie J, Golzio M, Rols MP . Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 2005; 1724: 270\u2013280.","journal-title":"Biochim Biophys Acta"},{"key":"BFcgt20106_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1046\/j.1365-201X.2003.01093.x","volume":"177","author":"J Gehl","year":"2003","unstructured":"Gehl J . Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437\u2013447.","journal-title":"Acta Physiol Scand"},{"key":"BFcgt20106_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2174\/156652309788921062","volume":"9","author":"SD Reed","year":"2009","unstructured":"Reed SD, Li S . Electroporation advances in large animals. Curr Gene Ther 2009; 9: 316\u2013326.","journal-title":"Curr Gene Ther"},{"key":"BFcgt20106_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/10837450802471180","volume":"14","author":"SM Sammeta","year":"2009","unstructured":"Sammeta SM, Vaka SR, Narasimha Murthy S . Transdermal drug delivery enhanced by low voltage electropulsation (LVE). Pharm Dev Technol 2009; 14: 159\u2013164.","journal-title":"Pharm Dev Technol"},{"key":"BFcgt20106_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-59745-429-2_10","volume":"480","author":"A Barbul","year":"2009","unstructured":"Barbul A, Antov Y, Rosenberg Y, Korenstein R . Enhanced delivery of macromolecules into cells by electroendocytosis. Methods Mol Biol 2009; 480: 141\u2013150.","journal-title":"Methods Mol Biol"},{"key":"BFcgt20106_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1245\/s10434-008-0204-8","volume":"16","author":"LG Campana","year":"2009","unstructured":"Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution\u2032s experience with 52 patients. Ann Surg Oncol 2009; 16: 191\u2013199.","journal-title":"Ann Surg Oncol"},{"key":"BFcgt20106_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1939-1676.2008.0117.x","volume":"22","author":"M Cemazar","year":"2008","unstructured":"Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D et al. Electrochemotherapy in veterinary oncology. J Vet Intern Med 2008; 22: 826\u2013831.","journal-title":"J Vet Intern Med"},{"key":"BFcgt20106_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.cr.7310025","volume":"16","author":"C Qian","year":"2006","unstructured":"Qian C, Liu XY, Prieto J . Therapy of cancer by cytokines mediated by gene therapy approach. Cell Res 2006; 16: 182\u2013188.","journal-title":"Cell Res"},{"key":"BFcgt20106_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14796694.1.1.57","volume":"1","author":"PL Lollini","year":"2005","unstructured":"Lollini PL, De Giovanni C, Pannellini T, Cavallo F, Forni G, Nanni P . Cancer immunoprevention. Future Oncol 2005; 1: 57\u201366.","journal-title":"Future Oncol"},{"issue":"Suppl 1","key":"BFcgt20106_CR12","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.suronc.2007.10.045","volume":"16","author":"L Mortara","year":"2007","unstructured":"Mortara L, Giuliani L, De Lerma Barbaro A, Accolla RS, Noonan DM . Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class II molecules combined with naked DNA interleukin-12 gene transfer. Surg Oncol 2007; 16 (Suppl 1): S33\u2013S36.","journal-title":"Surg Oncol"},{"key":"BFcgt20106_CR13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1517\/14712598.7.11.1705","volume":"7","author":"JM Weiss","year":"2007","unstructured":"Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH . Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 2007; 7: 1705\u20131721.","journal-title":"Expert Opin Biol Ther"},{"key":"BFcgt20106_CR14","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2174\/1381612033454261","volume":"9","author":"G Mazzolini","year":"2003","unstructured":"Mazzolini G, Prieto J, Melero I . Gene therapy of cancer with interleukin-12. Curr Pharm Des 2003; 9: 1981\u20131991.","journal-title":"Curr Pharm Des"},{"key":"BFcgt20106_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mam.2006.12.005","volume":"28","author":"L Persano","year":"2007","unstructured":"Persano L, Crescenzi M, Indraccolo S . Anti-angiogenic gene therapy of cancer: current status and future prospects. Mol Aspects Med 2007; 28: 87\u2013114.","journal-title":"Mol Aspects Med"},{"key":"BFcgt20106_CR16","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1200\/JCO.2007.15.6794","volume":"26","author":"AI Daud","year":"2008","unstructured":"Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896\u20135903.","journal-title":"J Clin Oncol"},{"key":"BFcgt20106_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1158\/1078-0432.CCR-05-1514","volume":"12","author":"MN Torrero","year":"2006","unstructured":"Torrero MN, Henk WG, Li S . Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res 2006; 12: 257\u2013263.","journal-title":"Clin Cancer Res"},{"key":"BFcgt20106_CR18","first-page":"1","volume-title":"Cancer Management: A Multidisciplinary Approach","author":"CE Takimoto CH","year":"2008","unstructured":"Takimoto CH CE . Principles of Oncologic Pharmacotherapy. In: Pazdur R WL, Camphausen KA, Hoskins WJ (eds). Cancer Management: A Multidisciplinary Approach. 11th edn, UBM Medical; London, England 2008, pp 1\u20139."},{"key":"BFcgt20106_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tvjl.2007.08.011","volume":"179","author":"EP Spugnini","year":"2009","unstructured":"Spugnini EP, Vincenzi B, Citro G, Tonini G, Dotsinsky I, Mudrov N et al. Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report. Vet J 2009; 179: 117\u2013120.","journal-title":"Vet J"},{"key":"BFcgt20106_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0305-7372(03)00073-2","volume":"29","author":"A Gothelf","year":"2003","unstructured":"Gothelf A, Mir LM, Gehl J . Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371\u2013387.","journal-title":"Cancer Treat Rev"},{"key":"BFcgt20106_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","volume":"34","author":"G Sersa","year":"2008","unstructured":"Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M . Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 2008; 34: 232\u2013240.","journal-title":"Eur J Surg Oncol"},{"key":"BFcgt20106_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ymthe.2003.08.002","volume":"8","author":"T Kishida","year":"2003","unstructured":"Kishida T, Asada H, Itokawa Y, Yasutomi K, Shin-Ya M, Gojo S et al. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 2003; 8: 738\u2013745.","journal-title":"Mol Ther"},{"key":"BFcgt20106_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/cyto.1997.0284","volume":"10","author":"M Buttner","year":"1998","unstructured":"Buttner M, Belke-Louis G, Rziha HJ, McInnes C, Kaaden OR . Detection, cDNA cloning and sequencing of canine interleukin 12. Cytokine 1998; 10: 241\u2013248.","journal-title":"Cytokine"},{"key":"BFcgt20106_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5326\/0410241","volume":"41","author":"N Ehrhart","year":"2005","unstructured":"Ehrhart N . Soft-tissue sarcomas in dogs: a review. J Am Anim Hosp Assoc 2005; 41: 241\u2013246.","journal-title":"J Am Anim Hosp Assoc"},{"key":"BFcgt20106_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nbt0906-1065b","volume":"24","author":"C Khanna","year":"2006","unstructured":"Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, Barber L et al. The dog as a cancer model. Nat Biotechnol 2006; 24: 1065\u20131066.","journal-title":"Nat Biotechnol"},{"key":"BFcgt20106_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-1-59745-194-9_24","volume":"423","author":"J Cutrera","year":"2008","unstructured":"Cutrera J, Torrero M, Shiomitsu K, Mauldin N, Li S . Intratumoral bleomycin and IL-2 electrochemogenetherapy for treating head and neck tumors in dogs. Meth Mol Biol 2008; 423: 319\u2013325.","journal-title":"Meth Mol Biol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt20106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20106","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:43:43Z","timestamp":1647949423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt20106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,12]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["BFcgt20106"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2010.6","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,12]]},"assertion":[{"value":"26 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}